Literature DB >> 21734124

Atypical lesions as a sign of cutaneous dissemination of visceral leishmaniasis in a human immunodeficiency virus-positive patient simultaneously infected by two viscerotropic Leishmania species.

Joanna R Santos-Oliveira1, Alda M Da-Cruz, Lucy H S Pires, Elisa Cupolillo, Katrin Kuhls, Carmem B W Giacoia-Gripp, Manoel P Oliveira-Neto.   

Abstract

Leishmaniasis is considered an emerging opportunistic disease in human immunodeficiency virus (HIV)-infected patients who have considerably variable clinical presentation. We report a patient with visceral leishmaniasis who had unexpected clinical aspects (atypical cutaneous lesions appearing after long-term evidence of visceral parasites). The patient had hepatoesplenomegaly in the absence of fever, but was otherwise generally healthy. The HIV viral load was low despite severe immunossupression (low lymphocyte proliferation and low level of interferon-γ, concomitant with a high lymphocyte activation status). Surprisingly, two Leishmania strains were isolated from his bone marrow (typical L. infantum sequence MON-1, type A) and skin (L. donovani MON-2 sequence); this second strain had not been previously identified in Brazil. The association of visceral leishmaniasis and HIV/acquired immunodeficiency syndrome is a largely unknown disease, particularly in areas in which leishmaniasis is not endemic. Such atypical cases indicate that this disease can be undiagnosed in clinical settings.

Entities:  

Mesh:

Year:  2011        PMID: 21734124      PMCID: PMC3122343          DOI: 10.4269/ajtmh.2011.10-0398

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  28 in total

1.  Cellular immune responses to Leishmania braziliensis in patients with AIDS-associated American cutaneous leishmaniasis.

Authors:  A M Da-Cruz; M Mattos; M P Oliveira-Neto; Z Coutinho; E S Machado; S G Coutinho
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.184

2.  Can immune markers predict subsequent discordance between immunologic and virologic responses to antiretroviral therapy? Adult AIDS Clinical Trials Group.

Authors:  John Spritzler; Donna Mildvan; Aleksandra Russo; Desh Asthana; Daniella Livnat; Barbara Schock; Jonathan Kagan; Alan Landay; David W Haas
Journal:  Clin Infect Dis       Date:  2003-07-29       Impact factor: 9.079

3.  Sudan: the possible original focus of visceral leishmaniasis.

Authors:  F Pratlong; J Dereure; B Bucheton; S El-Saf; A Dessein; G Lanotte; J P Dedet
Journal:  Parasitology       Date:  2001-06       Impact factor: 3.234

4.  Disseminated-to-skin kala-azar and the acquired immunodeficiency syndrome.

Authors:  M Yebra; J Segovia; L Manzano; J A Vargas; L Bernaldo de Quirós; J Alvar
Journal:  Ann Intern Med       Date:  1988-03       Impact factor: 25.391

5.  Unusual cutaneous lesions in two patients with visceral leishmaniasis and HIV infection.

Authors:  R Colebunders; K Depraetere; T Verstraeten; J Lambert; E Hauben; E Van Marck; T Maurer; A L Bañuls; J C Dujardin
Journal:  J Am Acad Dermatol       Date:  1999-11       Impact factor: 11.527

6.  [Cutaneo-visceral leishmaniasis: a new opportunistic infection in patients infected by HIV].

Authors:  R Botella Estrada; O Sanmartín Jiménez; M I Febrer Bosch; A Aliaga Boniche; M Salavert Lleti; P Roig Rico; A Nieto García; V Navarro Ibañez
Journal:  Med Cutan Ibero Lat Am       Date:  1990

Review 7.  Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.

Authors:  R Russo; F Laguna; R López-Vélez; F J Medrano; E Rosenthal; B Cacopardo; L Nigro
Journal:  Ann Trop Med Parasitol       Date:  2003-10

8.  Sequence analysis and PCR-RFLP profiling of the hsp70 gene as a valuable tool for identifying Leishmania species associated with human leishmaniasis in Brazil.

Authors:  Leonardo Alves da Silva; Cíntia Dos Santos de Sousa; Grazielle Cardoso da Graça; Renato Porrozzi; Elisa Cupolillo
Journal:  Infect Genet Evol       Date:  2009-11-11       Impact factor: 3.342

9.  Distribution of naive and memory/effector CD4 + T lymphocytes and expression of CD38 on CD8 + T lymphocytes in AIDS patients with tuberculosis.

Authors:  Denise do Socorro S Rodrigues; Rosangela M de C Cunha; Esper Georges Kallas; Reinaldo Salomao
Journal:  Braz J Infect Dis       Date:  2003-04       Impact factor: 1.949

10.  Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDS.

Authors:  Leonardo Calza; Antonietta D'Antuono; Ginevra Marinacci; Roberto Manfredi; Vincenzo Colangeli; Beatrice Passarini; Roberto Orioli; Ornella Varoli; Francesco Chiodo
Journal:  J Am Acad Dermatol       Date:  2004-03       Impact factor: 11.527

View more
  7 in total

Review 1.  Visceral leishmaniasis and HIV coinfection in Latin America.

Authors:  José Angelo Lindoso; Gláucia Fernandes Cota; Alda Maria da Cruz; Hiro Goto; Ana Nilce Silveira Maia-Elkhoury; Gustavo Adolfo Sierra Romero; Márcia Leite de Sousa-Gomes; Joanna Reis Santos-Oliveira; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2014-09-18

Review 2.  PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses.

Authors:  Eduard E Zijlstra
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

3.  Immune Activation and Bacterial Translocation: A Link between Impaired Immune Recovery and Frequent Visceral Leishmaniasis Relapses in HIV-Infected Patients.

Authors:  Maria Luciana Silva-Freitas; Glaucia Fernandes Cota; Talia S Machado-de-Assis; Carmem Giacoia-Gripp; Ana Rabello; Alda M Da-Cruz; Joanna R Santos-Oliveira
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

4.  An unusual presentation of leishmaniasis in a human immunodeficiency virus-positive individual.

Authors:  Marijo S Roiko; Bryan H Schmitt; Ryan F Relich; Thomas L Meyer; Shanxiang Zhang; Thomas E Davis
Journal:  JMM Case Rep       Date:  2016-02-05

Review 5.  Atypical leishmaniasis: A global perspective with emphasis on the Indian subcontinent.

Authors:  Lovlesh Thakur; Kiran K Singh; Vinay Shanker; Ajeet Negi; Aklank Jain; Greg Matlashewski; Manju Jain
Journal:  PLoS Negl Trop Dis       Date:  2018-09-27

Review 6.  Determinants for the development of visceral leishmaniasis disease.

Authors:  Laura-Isobel McCall; Wen-Wei Zhang; Greg Matlashewski
Journal:  PLoS Pathog       Date:  2013-01-03       Impact factor: 6.823

7.  Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.

Authors:  K K G D U L Kariyawasam; A Selvapandiyan; H V Y D Siriwardana; A Dube; P Karunanayake; S A S C Senanayake; R Dey; S Gannavaram; H L Nakhasi; N D Karunaweera
Journal:  Parasitology       Date:  2017-11-08       Impact factor: 3.234

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.